Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0A4J

Astrazeneca (0A4J)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0A4J
DateTimeSourceHeadlineSymbolCompany
03/01/202402:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
27/12/202318:00UK RegulatoryAstraZeneca PLC AstraZeneca acquires GracellLSE:0A4JAstrazeneca Plc
22/12/202318:00UK RegulatoryAstraZeneca PLC Wainua (eplontersen) granted first US FDA approvalLSE:0A4JAstrazeneca Plc
15/12/202302:00UK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
12/12/202318:05UK RegulatoryAstraZeneca PLC AstraZeneca to acquire IcosavaxLSE:0A4JAstrazeneca Plc
02/12/202302:05UK RegulatoryAstraZeneca PLC Block listing Interim ReviewLSE:0A4JAstrazeneca Plc
02/12/202302:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
01/12/202318:00UK RegulatoryAstraZeneca PLC Discontinuation of two CRYSTALIZE evidence trialsLSE:0A4JAstrazeneca Plc
24/11/202302:00UK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
17/11/202318:00UK RegulatoryAstraZeneca PLC Truqap approved in US for HR+ breast cancerLSE:0A4JAstrazeneca Plc
14/11/202318:05UK RegulatoryAstraZeneca PLC Update on PACIFIC-2 Phase III trial for ImfinziLSE:0A4JAstrazeneca Plc
10/11/202302:00UK RegulatoryAstraZeneca PLC Director DeclarationLSE:0A4JAstrazeneca Plc
09/11/202318:10UK RegulatoryAstraZeneca PLC Imfinzi combination improves PFS in liver cancerLSE:0A4JAstrazeneca Plc
09/11/202318:05UK RegulatoryAstraZeneca PLC Agreement with Eccogene for clinical stage GLP-1RALSE:0A4JAstrazeneca Plc
09/11/202318:00UK RegulatoryAstraZeneca PLC 9M and Q3 2023 resultsLSE:0A4JAstrazeneca Plc
02/11/202302:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
01/11/202318:00UK RegulatoryAstraZeneca PLC AstraZeneca cell & gene therapy deal w/ CellectisLSE:0A4JAstrazeneca Plc
03/10/202317:00UK RegulatoryAstraZeneca PLC AstraZeneca settles Nexium liability litigationsLSE:0A4JAstrazeneca Plc
03/10/202301:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
22/09/202316:00UK RegulatoryAstraZeneca PLC Dato-DXd improved PFS in breast cancerLSE:0A4JAstrazeneca Plc
20/09/202316:00UK RegulatoryAstraZeneca PLC Alexion completes Pfizer gene therapy agreementLSE:0A4JAstrazeneca Plc
16/09/202300:00UK RegulatoryAstraZeneca PLC Enhertu recommended in EU for HER2-mutant NSCLCLSE:0A4JAstrazeneca Plc
12/09/202301:00UK RegulatoryAstraZeneca PLC Fasenra Phase III EGPA trial met primary endpointLSE:0A4JAstrazeneca Plc
06/09/202316:00UK RegulatoryAstraZeneca PLC Update on US review of Ultomiris for NMOSDLSE:0A4JAstrazeneca Plc
02/09/202300:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
02/08/202300:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
28/07/202316:05UK RegulatoryAstraZeneca PLC Alexion enters gene therapy agreement with PfizerLSE:0A4JAstrazeneca Plc
28/07/202316:00UK RegulatoryAstraZeneca PLC Half-year ReportLSE:0A4JAstrazeneca Plc
18/07/202303:10UK RegulatoryAstraZeneca PLC Beyfortus approved in US for infant RSV preventionLSE:0A4JAstrazeneca Plc
04/07/202300:00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:0A4J